Company News For Dec 27, 2018

Zacks Equity Research Published on December 27, 2018

Intel Corporation’s (INTC - Free Report) shares jumped 6% after the company was given a grant of $185 million by the Israeli government in return for a $5 billion expansion of it chip-making operations in that country
Shares of JD.com, Inc. (JD - Free Report) rallied 6.8% after a share buyback program of up to $1 billion was authorized by the company’s board, which would be executed over the next 12 months
Teva Pharmaceutical Industries Limited’s (TEVA - Free Report) shares surged 8.4% after Neos Therapeutics, Inc. said that it has entered a confidential licensing and settlement agreement with the company in a move to resolve patent litigation related to a ADHD treatment
Shares of Expedia Group, Inc. (EXPE - Free Report) increased 4.7% on reports that the company has entered the final stages of negotiations with Marriott International, Inc. (MAR - Free Report) over how much fees the hotel company will pay the online booking giant

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.